Group 1 - The stock of Xiaofang Pharmaceutical (603207) increased by 6.18% with a turnover rate of 30.15% and a trading volume of 439 million yuan, showing a fluctuation of 9.98% [2] - Institutional investors net bought 10.28 million yuan while the total net selling by brokerage seats amounted to 24.11 million yuan [2] - The stock was listed on the Shanghai Stock Exchange due to its turnover rate reaching 30.15%, with a significant net inflow of 38.57 million yuan from main funds [2] Group 2 - In the first quarter, Xiaofang Pharmaceutical reported a revenue of 129 million yuan, representing a year-on-year growth of 3.33%, and a net profit of 59.84 million yuan, which is a 14.63% increase compared to the previous year [2] - The top five brokerage seats accounted for a total transaction volume of 120 million yuan, with a buying amount of 52.90 million yuan and a selling amount of 66.72 million yuan, resulting in a net selling of 13.83 million yuan [2] - The main funds saw a net inflow of 54.88 million yuan over the past five days [2]
小方制药8月1日龙虎榜数据